nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—sarcoma—salivary gland cancer	0.588	1	CtDrD
Mitoxantrone—TOP2A—salivary gland cancer	0.369	1	CbGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGFR4—salivary gland cancer	0.000181	0.00415	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—MAP2K2—salivary gland cancer	0.000175	0.00402	CbGpPWpGaD
Mitoxantrone—BTK—FAS (CD95) signaling pathway—PIK3CA—salivary gland cancer	0.000168	0.00385	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGFR4—salivary gland cancer	0.000167	0.00384	CbGpPWpGaD
Mitoxantrone—BTK—EPO signaling pathway—HRAS—salivary gland cancer	0.000166	0.00382	CbGpPWpGaD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.000166	0.00381	CbGpPWpGaD
Mitoxantrone—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.000165	0.00379	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—MAP2K2—salivary gland cancer	0.000165	0.00378	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000162	0.00373	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FOXO3—salivary gland cancer	0.000159	0.00366	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.000157	0.0036	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—GINS2—salivary gland cancer	0.000152	0.0035	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—PRKDC—salivary gland cancer	0.000151	0.00346	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FOXO3—salivary gland cancer	0.00015	0.00344	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FOXO3—salivary gland cancer	0.00015	0.00344	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—EP300—salivary gland cancer	0.000149	0.00342	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—MAP2K2—salivary gland cancer	0.000148	0.00341	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.000147	0.00337	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000143	0.00328	CbGpPWpGaD
Mitoxantrone—BTK—BCR signaling pathway—PTEN—salivary gland cancer	0.000141	0.00324	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FOXO3—salivary gland cancer	0.000139	0.00319	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—PIK3CA—salivary gland cancer	0.000137	0.00315	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—GINS2—salivary gland cancer	0.000136	0.00313	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—CREBBP—salivary gland cancer	0.000135	0.00309	CbGpPWpGaD
Mitoxantrone—BTK—TSLP Signaling Pathway—PIK3CA—salivary gland cancer	0.000132	0.00304	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000132	0.00303	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—MAP2K2—salivary gland cancer	0.00013	0.00299	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—HRAS—salivary gland cancer	0.000127	0.00291	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—MAP2K2—salivary gland cancer	0.000122	0.00281	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—MAP2K2—salivary gland cancer	0.000122	0.00281	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—salivary gland cancer	0.000116	0.00267	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—DTX4—salivary gland cancer	0.000115	0.00264	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—ESPL1—salivary gland cancer	0.00011	0.00252	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000108	0.00249	CbGpPWpGaD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—PIK3CA—salivary gland cancer	0.000107	0.00247	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000105	0.0024	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CYLD—salivary gland cancer	0.000104	0.00239	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—HRAS—salivary gland cancer	0.000102	0.00234	CbGpPWpGaD
Mitoxantrone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.000102	0.00234	CbGpPWpGaD
Mitoxantrone—BTK—BCR signaling pathway—PIK3CA—salivary gland cancer	9.96e-05	0.00229	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PRKDC—salivary gland cancer	9.96e-05	0.00229	CbGpPWpGaD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—HRAS—salivary gland cancer	9.94e-05	0.00228	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—ESPL1—salivary gland cancer	9.79e-05	0.00225	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	9.53e-05	0.00219	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	9.5e-05	0.00218	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF16—salivary gland cancer	9.5e-05	0.00218	CbGpPWpGaD
Mitoxantrone—BTK—BCR signaling pathway—HRAS—salivary gland cancer	9.22e-05	0.00212	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—EP300—salivary gland cancer	9.18e-05	0.00211	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF16—salivary gland cancer	9.12e-05	0.0021	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	8.97e-05	0.00206	CbGpPWpGaD
Mitoxantrone—BTK—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—salivary gland cancer	8.56e-05	0.00197	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	7.93e-05	0.00182	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	7.92e-05	0.00182	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	7.92e-05	0.00182	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—salivary gland cancer	7.72e-05	0.00177	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGFR4—salivary gland cancer	7.02e-05	0.00161	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—NUP62—salivary gland cancer	6.94e-05	0.00159	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—PTEN—salivary gland cancer	6.9e-05	0.00158	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—HRAS—salivary gland cancer	6.86e-05	0.00157	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGFR4—salivary gland cancer	6.74e-05	0.00155	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—salivary gland cancer	6.73e-05	0.00154	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—DTX4—salivary gland cancer	6.69e-05	0.00154	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FBXW7—salivary gland cancer	6.63e-05	0.00152	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—PTEN—salivary gland cancer	6.49e-05	0.00149	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	6.49e-05	0.00149	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	6.4e-05	0.00147	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	6.3e-05	0.00145	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—NUP62—salivary gland cancer	6.21e-05	0.00143	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CYLD—salivary gland cancer	6.05e-05	0.00139	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—PTEN—salivary gland cancer	6.01e-05	0.00138	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FOXO3—salivary gland cancer	5.82e-05	0.00134	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—SMC1A—salivary gland cancer	5.81e-05	0.00133	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PRKDC—salivary gland cancer	5.8e-05	0.00133	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FOXO3—salivary gland cancer	5.59e-05	0.00128	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	5.56e-05	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	5.56e-05	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF16—salivary gland cancer	5.53e-05	0.00127	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CCND1—salivary gland cancer	5.43e-05	0.00125	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	5.42e-05	0.00124	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	5.4e-05	0.00124	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NUP62—salivary gland cancer	5.31e-05	0.00122	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—SMC1A—salivary gland cancer	5.2e-05	0.00119	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	5.15e-05	0.00118	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—salivary gland cancer	5.09e-05	0.00117	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	4.97e-05	0.00114	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—PIK3CA—salivary gland cancer	4.87e-05	0.00112	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAP2K2—salivary gland cancer	4.76e-05	0.00109	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—PIK3CA—salivary gland cancer	4.58e-05	0.00105	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	4.58e-05	0.00105	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—HRAS—salivary gland cancer	4.5e-05	0.00103	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	4.37e-05	0.001	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ISYNA1—salivary gland cancer	4.31e-05	0.00099	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	4.29e-05	0.000984	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—PIK3CA—salivary gland cancer	4.24e-05	0.000973	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—HRAS—salivary gland cancer	4.24e-05	0.000973	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	4.24e-05	0.000973	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ISYNA1—salivary gland cancer	4.17e-05	0.000958	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	4.12e-05	0.000945	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—BRCA1—salivary gland cancer	4.11e-05	0.000944	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR4—salivary gland cancer	4.09e-05	0.000939	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	4.06e-05	0.000932	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—WNT5B—salivary gland cancer	4.04e-05	0.000928	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FBXW7—salivary gland cancer	4.02e-05	0.000923	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	3.97e-05	0.000912	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	3.94e-05	0.000905	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—HRAS—salivary gland cancer	3.92e-05	0.000901	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	3.91e-05	0.000899	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CPSF4—salivary gland cancer	3.9e-05	0.000896	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PYGB—salivary gland cancer	3.9e-05	0.000896	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL17RD—salivary gland cancer	3.9e-05	0.000896	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—PTEN—salivary gland cancer	3.81e-05	0.000876	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ISYNA1—salivary gland cancer	3.79e-05	0.000871	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	3.79e-05	0.00087	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—EP300—salivary gland cancer	3.64e-05	0.000835	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAML3—salivary gland cancer	3.57e-05	0.000819	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CREBBP—salivary gland cancer	3.53e-05	0.000811	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MARCKS—salivary gland cancer	3.51e-05	0.000807	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	3.47e-05	0.000797	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MARCKS—salivary gland cancer	3.4e-05	0.000781	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FOXO3—salivary gland cancer	3.39e-05	0.000779	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDH1—salivary gland cancer	3.37e-05	0.000773	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PYGB—salivary gland cancer	3.27e-05	0.00075	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PYGB—salivary gland cancer	3.16e-05	0.000726	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	3.13e-05	0.000718	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MARCKS—salivary gland cancer	3.09e-05	0.00071	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ST3GAL4—salivary gland cancer	3.06e-05	0.000703	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	2.92e-05	0.00067	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PYGB—salivary gland cancer	2.88e-05	0.00066	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	2.8e-05	0.000643	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DTX4—salivary gland cancer	2.78e-05	0.000638	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—ATM—salivary gland cancer	2.77e-05	0.000636	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAP2K2—salivary gland cancer	2.77e-05	0.000636	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ISYNA1—salivary gland cancer	2.72e-05	0.000625	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	2.71e-05	0.000623	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PHGDH—salivary gland cancer	2.66e-05	0.000612	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—salivary gland cancer	2.6e-05	0.000598	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PHGDH—salivary gland cancer	2.58e-05	0.000592	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ST3GAL4—salivary gland cancer	2.56e-05	0.000589	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PTEN—salivary gland cancer	2.52e-05	0.000579	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ST3GAL4—salivary gland cancer	2.48e-05	0.000569	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTEN—salivary gland cancer	2.42e-05	0.000556	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EP300—salivary gland cancer	2.41e-05	0.000552	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	2.36e-05	0.000543	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PHGDH—salivary gland cancer	2.34e-05	0.000538	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AQP1—salivary gland cancer	2.33e-05	0.000535	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF16—salivary gland cancer	2.3e-05	0.000528	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	2.26e-05	0.000518	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AQP1—salivary gland cancer	2.25e-05	0.000517	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MARCKS—salivary gland cancer	2.22e-05	0.00051	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NUP62—salivary gland cancer	2.2e-05	0.000506	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—VCAN—salivary gland cancer	2.19e-05	0.000502	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	2.11e-05	0.000484	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PYGB—salivary gland cancer	2.06e-05	0.000474	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CREBBP—salivary gland cancer	2.06e-05	0.000472	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ISYNA1—salivary gland cancer	2.05e-05	0.000471	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AQP1—salivary gland cancer	2.05e-05	0.00047	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDH1—salivary gland cancer	2.04e-05	0.000469	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAML2—salivary gland cancer	2e-05	0.000459	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—salivary gland cancer	1.99e-05	0.000457	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	1.88e-05	0.000431	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NUP62—salivary gland cancer	1.85e-05	0.000424	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.83e-05	0.000421	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—VCAN—salivary gland cancer	1.83e-05	0.000421	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	1.83e-05	0.000421	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NUP62—salivary gland cancer	1.79e-05	0.00041	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—salivary gland cancer	1.78e-05	0.000409	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—salivary gland cancer	1.78e-05	0.000409	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—VCAN—salivary gland cancer	1.77e-05	0.000407	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—salivary gland cancer	1.71e-05	0.000392	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAG1—salivary gland cancer	1.71e-05	0.000392	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR4—salivary gland cancer	1.7e-05	0.00039	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PHGDH—salivary gland cancer	1.68e-05	0.000386	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MARCKS—salivary gland cancer	1.67e-05	0.000384	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FBXW7—salivary gland cancer	1.67e-05	0.000384	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—salivary gland cancer	1.65e-05	0.000378	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—EP300—salivary gland cancer	1.64e-05	0.000377	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NUP62—salivary gland cancer	1.62e-05	0.000373	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ST3GAL4—salivary gland cancer	1.62e-05	0.000372	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—VCAN—salivary gland cancer	1.61e-05	0.00037	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.61e-05	0.000369	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—salivary gland cancer	1.58e-05	0.000363	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.55e-05	0.000357	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PYGB—salivary gland cancer	1.55e-05	0.000357	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.53e-05	0.000351	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AQP1—salivary gland cancer	1.47e-05	0.000338	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—salivary gland cancer	1.47e-05	0.000337	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FOXO3—salivary gland cancer	1.41e-05	0.000324	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EP300—salivary gland cancer	1.4e-05	0.000322	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	1.36e-05	0.000311	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.35e-05	0.000309	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	1.31e-05	0.0003	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PHGDH—salivary gland cancer	1.27e-05	0.000291	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	1.26e-05	0.00029	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	1.25e-05	0.000286	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	1.22e-05	0.00028	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—salivary gland cancer	1.17e-05	0.000269	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NUP62—salivary gland cancer	1.17e-05	0.000268	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—VCAN—salivary gland cancer	1.16e-05	0.000266	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAP2K2—salivary gland cancer	1.15e-05	0.000264	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.15e-05	0.000264	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.11e-05	0.000255	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AQP1—salivary gland cancer	1.11e-05	0.000254	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.09e-05	0.000251	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.06e-05	0.000243	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—salivary gland cancer	1.04e-05	0.000238	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MARCKS—salivary gland cancer	1.03e-05	0.000237	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—salivary gland cancer	9.59e-06	0.00022	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PYGB—salivary gland cancer	9.58e-06	0.00022	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—salivary gland cancer	9.43e-06	0.000217	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	9.23e-06	0.000212	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	8.93e-06	0.000205	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NUP62—salivary gland cancer	8.78e-06	0.000202	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—VCAN—salivary gland cancer	8.71e-06	0.0002	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREBBP—salivary gland cancer	8.55e-06	0.000196	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.1e-06	0.000186	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.83e-06	0.00018	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PHGDH—salivary gland cancer	7.81e-06	0.000179	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	7.52e-06	0.000173	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	7.27e-06	0.000167	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CREBBP—salivary gland cancer	7.16e-06	0.000164	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CREBBP—salivary gland cancer	6.92e-06	0.000159	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AQP1—salivary gland cancer	6.82e-06	0.000157	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CREBBP—salivary gland cancer	6.3e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—salivary gland cancer	6.11e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—salivary gland cancer	5.82e-06	0.000134	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NUP62—salivary gland cancer	5.41e-06	0.000124	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—VCAN—salivary gland cancer	5.37e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—salivary gland cancer	5.11e-06	0.000117	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—salivary gland cancer	4.95e-06	0.000114	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—salivary gland cancer	4.88e-06	0.000112	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—salivary gland cancer	4.72e-06	0.000108	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CREBBP—salivary gland cancer	4.52e-06	0.000104	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—salivary gland cancer	4.5e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—salivary gland cancer	4.31e-06	9.89e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—salivary gland cancer	4.29e-06	9.85e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—salivary gland cancer	3.98e-06	9.15e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—salivary gland cancer	3.61e-06	8.28e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—salivary gland cancer	3.49e-06	8.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CREBBP—salivary gland cancer	3.41e-06	7.82e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—salivary gland cancer	3.23e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—salivary gland cancer	3.17e-06	7.29e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—salivary gland cancer	3.08e-06	7.07e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—salivary gland cancer	2.43e-06	5.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—salivary gland cancer	2.32e-06	5.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—salivary gland cancer	2.28e-06	5.23e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.1e-06	4.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.72e-06	3.94e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—salivary gland cancer	1.5e-06	3.44e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—salivary gland cancer	1.43e-06	3.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.06e-06	2.43e-05	CbGpPWpGaD
